Monte Rosa Therapeutics · 4 days ago
Senior Accountant – SEC Reporting & Compliance
Monte Rosa Therapeutics is seeking an experienced Senior Accountant to play a key role in the Company’s SEC reporting, audit management, and SOX 404(b) implementation. This position will also support income tax provision activities and month-end close procedures.
BiotechnologyMedicalTherapeutics
Responsibilities
Prepare quarterly and annual SEC filings, including Forms 10-Q, 10-K, and related disclosures
Prepare financial statements, footnotes, and supporting schedules in accordance with U.S. GAAP
Support the quarterly and annual income tax provision, including tax-related financial statement disclosures, in coordination with external tax advisors
Assist with technical accounting research and preparation of accounting position memos for complex or non-routine transactions
Support implementation and documentation of new accounting standards and updates
Maintain and enhance accounting policies and procedures
Assist with disclosure for the quarterly provision for income taxes
Serve as a liaison with external auditors for quarterly reviews and annual audits
Coordinate audit requests, prepare supporting documentation, and resolve audit inquiries
Support the implementation of SOX 404(b), including control design, documentation, testing, and remediation
Assist in maintaining effective internal controls over financial reporting
Participate in the monthly close process, including preparation of journal entries, account reconciliations, and variance analyses
Ensure accurate and timely close in accordance with internal deadlines
Collaborate cross-functionally with FP&A, Legal, Tax, and other stakeholders
Qualification
Required
Bachelor's degree in Accounting or Finance
4–7+ years of relevant accounting experience
Hands-on experience with SEC reporting in a public company environment
Strong knowledge of U.S. GAAP, financial reporting, and internal controls
Experience with SOX 404(b) implementation or compliance
Strong organizational, analytical, and communication skills
Ability to manage multiple priorities in a fast-paced, deadline-driven environment
Preferred
CPA
Public accounting experience (Big 4 or national firm)
Life sciences or biotech industry experience
Company
Monte Rosa Therapeutics
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.
Funding
Current Stage
Public CompanyTotal Funding
$648.5MKey Investors
Avoro Capital AdvisorsAisling Capital
2026-01-08Post Ipo Equity· $300M
2024-05-15Post Ipo Equity· $100M
2023-10-26Post Ipo Equity· $25M
Recent News
2026-01-11
2026-01-09
BioWorld Financial Watch
2026-01-09
Company data provided by crunchbase